2
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Consensus to identify the dangerous drugs risks in hospital pharmacy services Translated title: Consenso para identificar los riesgos de los medicamentos peligrosos en los servicios de farmacia hospitalaria

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abstract Objective: To identify the hazards and define the theoretical occupa tional risks arising from the process of handling hazard drugs in hospital pharmacy services on the basis of expert consensus. Method: An expert consensus was conducted (nominal group and documentary techniques) using a mixed method of two face-to-face rounds (meeting of participants and approval of proposals) and three masked rounds (individualized review). The analysis was applied to the field of hospital pharmacy. The stages of the process were desig ned using the standardized graphical Business Process Model and Notation. Results: A specific flowchart was obtained for the management and tra ceability of hazardous drugs. All general process phases were characte rized. A management chart included operations addressing the reception and storage, compounding, conservation, and dispensation of hazardous drugs in hospital pharmacy services. This chart provides a description of the chemical hazards and exposure routes. Conclusions: The hazardous drug process should be integrated in a standard management system to improve the safety of patients and health care professionals. Efficiency can maximized and procedural incidents minimized, thereby ensuring the quality and the safety of hazardous drugs handling in hospital pharmacy services. Once hazards are identified, risk assessment should be implemented using a systematic and preventative methodology to minimize the risk and seve rity of any adverse event.

          Translated abstract

          Resumen Objetivo: Identificar los peligros y definir los riesgos laborales teóricos derivados del proceso de manipulación de los medicamentos peligrosos en los servicios de farmacia hospitalaria mediante un consenso de expertos. Método: Se realizó un consenso de expertos (grupo nominal y técnicas documentales) utilizando un método mixto mediante dos rondas presenciales (reunión de los participantes y aprobación de propuestas) y tres rondas en mascaradas (revisión del material de forma individual). El análisis se aplicó al ámbito de la farmacia hospitalaria y las etapas del proceso se diseñaron mediante notación gráfica normalizada Business Process Modeling Notation. Resultados: Se obtuvo el diagrama de flujo específico para la gestión y trazabilidad de los medicamentos peligrosos, caracterizándose cada una de las fases del proceso general, recopiladas en un cuadro de gestión de etapas y operaciones de recepción y almacenamiento, elaboración, con servación y dispensación de medicamentos peligrosos en los servicios de farmacia hospitalaria, que sirvió para la posterior descripción de riesgos químicos y vías de exposición. Conclusiones: Los medicamentos peligrosos deben integrarse en un sistema normalizado de gestión con el fin de mejorar la seguridad del paciente y de los profesionales sanitarios, a la vez que se maximizan la efi ciencia de los recursos y minimizan los incidentes procesales, garantizando la calidad y la seguridad del proceso de manipulación de medicamentos peligrosos en los servicios de farmacia. Sería deseable, una vez se han identificado los peligros, llevar a cabo una evaluación de los riesgos siguiendo una metodología sistemática y de abordaje preventivo que permita calibrar la probabilidad de ocurrencia y la gravedad de cualquier suceso adverso.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          ISOPP standards of practice. Safe handling of cytotoxics.

          (2007)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists.

            Insult to the germ cells of an ovum or sperm prior to pregnancy as well as exposures to a fetus during pregnancy can affect the outcome of a pregnancy. Antineoplastic agents are mutagenic and teratogenic, so the potential effects of exposure on reproduction are of concern to the workers who handle them. This study investigates pregnancy loss associated with occupational exposures to antineoplastic drugs by comparing rates of spontaneous abortion and stillbirths for pregnancies without antineoplastic exposure and exposed pregnancies in which the pregnant woman or the father handled antineoplastic agents either before or during the pregnancy. A total of 7094 pregnancies of 2976 pharmacy and nursing staff were examined. After age during pregnancy, prior gravidity, maternal smoking during the pregnancy, and occurrence of a spontaneous abortion or stillbirth in a prior pregnancy were controlled for, exposure of the mother to or the handling of antineoplastic agents during the pregnancy was associated with a significantly increased risk of spontaneous abortion (odds ratio = 1.5; 95% confidence interval, 1.2 to 1.8) and combined risk of spontaneous abortion and stillbirth (odds ratio = 1.4; 95% confidence interval, 1.2 to 1.7) but not stillbirth alone. Among the wives of exposed men, too few stillbirths occurred to allow analysis. However, for spontaneous abortion and any loss, the patterns of increased risk were similar to those seen for women, although the odds ratios were not statistically significant.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Guidelines for safe handling of hazardous drugs: A systematic review

              Objective To review the scientific literature related to the safe handling of hazardous drugs (HDs). Method Critical analysis of works retrieved from MEDLINE, the Cochrane Library, Scopus, CINHAL, Web of Science and LILACS using the terms "Hazardous Substances", "Antineoplastic Agents" and "Cytostatic Agents", applying "Humans" and "Guidelines" as filters. Date of search: January 2017. Results In total, 1100 references were retrieved, and from those, 61 documents were selected based on the inclusion and exclusion criteria: 24 (39.3%) documents related to recommendations about HDs; 27 (44.3%) about antineoplastic agents, and 10 (33.3%) about other types of substances (monoclonal antibodies, gene medicine and other chemical and biological agents). In 14 (23.3%) guides, all the stages in the manipulation process involving a risk due to exposure were considered. Only one guide addressed all stages of the handling process of HDs (including stages with and without the risk of exposure). The most described stages were drug preparation (41 guides, 67.2%), staff training and/or patient education (38 guides, 62.3%), and administration (37 guides, 60.7%). No standardized informatics system was found that ensured quality management, traceability and minimization of the risks associated with these drugs. Conclusions Most of the analysed guidelines limit their recommendations to the manipulation of antineoplastics. The most frequently described activities were preparation, training, and administration. It would be convenient to apply ICTs (Information and Communications Technologies) to manage processes involving HDs in a more complete and simpler fashion.
                Bookmark

                Author and article information

                Journal
                fh
                Farmacia Hospitalaria
                Farm Hosp.
                Grupo Aula Médica (Toledo, Toledo, Spain )
                1130-6343
                2171-8695
                April 2020
                : 44
                : 2
                : 51-61
                Affiliations
                [2] orgnameHospital General Universitario de Alicante orgdiv1Servicio de Farmacia de Área Spain
                [6] Valencia orgnameUniversidad de Alicante Spain
                [5] orgnameHospital General Universitario de Alicante orgdiv1Unidad de Hospitalización a Domicilio Spain
                [3] orgnameHospital General Universitario de Alicante orgdiv1Servicio de Farmacia Spain
                [4] orgnameHospital General Universitario de Elche orgdiv1Servicio de Farmacia Spain
                [1] Valencia orgnameUniversidad Miguel Hernández de Elche orgdiv1Departamento de Salud Pública e Historia de la Ciencia Spain
                Article
                S1130-63432020000200051 S1130-6343(20)04400200051
                10.7399/fh.11290
                32452316
                110c4947-ba48-4481-9150-b6c138a81a17

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                : 23 September 2019
                : 14 June 2019
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 27, Pages: 11
                Product

                SciELO Spain

                Categories
                Originals

                Quality control,Cytostatic agents,Process assessment,Information management,Occupational health,Sustancias peligrosas,Antineoplásicos,Citostáticos,Salud laboral,Control de calidad,Evaluación del proceso,Gestión de la información,Hazardous substances,Antineoplastic agents

                Comments

                Comment on this article